Dr. Emanuel Revici Therapy
The Revici Method is treatment of cancer developed by Emanuel Revici, MD. Dr. Revici believed that pathologic conditions were due to a chemical imbalance within the body that could be modified using natural substance. Revici’s cancer therapy was a nontoxic chemotherapy that used lipids, lipid-based substances, and essential elements to correct an underlying imbalance in the patient’s chemistry.
His method was a blend of clinical observations, laboratory analyses, and chemotherapy. Basically, Revici would analyze the urine, blood, and body temperature and place patients in specific categories based on the "imbalance" that was discovered from these tests. He knew that low body temperature tracks perfectly with immune system strength.
The Romanian-born physician, who practiced in New York City, applied his wide-ranging discoveries for over sixty years to the treatment of cancer as well as many other disorders, including AIDS, arthritis, Alzheimer’s disease, chronic pain, drug addiction, schizophrenia, allergies, shock, and burns. The great majority of his cancer patients were in advanced stages of the illness.
Dr. Revici was the first physician to develop selenium compounds by chemically bonding the mineral selenium to a lipid. Independent validations of Revici’s findings accumulated over the years concerning the development of a safe, effective means of administering selenium to treat cancer.
Revici, who died at a ripe old age of 101, was hounded by the authorities of his time. Dr. Seymour Brenner, a respected radiation oncologist in private practice in New York, testified on Revici’s behalf. He had investigated a number of patients in very advanced stages of cancer, incurable by orthodox means, whom Revici had put into long remissions. Dr. Brenner had an independent panel of pathologists confirm the diagnosis and stage of illness prior to each patient’s initial visit to Revici. He testified that his personal findings strongly suggest Revici has a cancer treatment deserving further study, and he proposed that such an evaluation be conducted by the FDA.
One of his titanic discoveries was understanding the process of what has become known as the anabolic/catabolic metabolic balance. The anabolic/catabolic forces are involved in almost everything in the body. Failing to understand the importance of these fundamental life processes could cost you your health.
Dr. Revici's text: "Research in Physiopathology as Basis of Guided Chemotherapy" was published in 1961. This text is extraordinarily complex, is out of print and is very difficult to find. It yields an incredible amount of vital information regarding Revici's complex theories, the effects of electrostatic and quantum forces upon the body, his explanation of the anaerobic and dysaerobic factors, various orthomolecular agents that are effective at controlling these imbalances, and much more than this.
Dr. Revici successfully cured patients of cancer, put full blown AIDS patients into remission, cured heroin addiction in 3 days, successfully treated mental illness and significantly improved people's lives and reduced human suffering.
Cellular metabolism is the fundamental process with how energy can be produced from nutrients and oxygen. Understanding the differences between the 2 metabolic states of anaerobic and dysaerobic can mean the difference between life and death, health and disease and fast recovery versus slow recovery. There is probably not a single clinical health condition that does not involve an anaerobic or dysaerobic imbalance.
Revici is recognized as the first physician to demonstrate the potency of the trace mineral Selenium in various cancers and states of metabolic imbalance. His discoveries of selenium pre-dated conventional understanding by several decades.
Anaerobic metabolism is the anabolic processes of cellular building. In an anaerobic imbalance there is excess anabolic activity taking place. Instead of producing energy with oxygen, a person is relying on lactic acid fermentation. This is very inefficient. Because an anaerobic patient tends to have a decrease in cell membrane permeability, there is insufficient fatty acid activity and excess sterol activity. When anaerobic conditions are prevalent, cell membranes are too tight, nutrients and oxygen are not used properly by the cells. This contributes to excess intra-cellular acidity, excess potassium in the cells and can derail function in various organs, and systems in the body.
Revici used various methods to determine anaerobic/dysaerobic imbalances. He had a very complex way of interpreting blood chemistry, which included the importance of measuring the levels of intracellular (not serum) potassium. He also used urine testing such as the measurement of urinary surface tension, specific gravity and urine pH.
Dr. Revici’s observations led him to the discovery of “therapeutic agents”, as he called select lipids he administered to countless patients during a span of seven decades. These lipids not only induced significant remissions in many cancers, they did so without any side effects.
Dr. Revici also proved his therapeutic lipids were very effective in the treatment of a host of acute and chronic conditions besides cancer. These include hypertension, cardiovascular disease, addictions, diabetes and autoimmune diseases. Therapeutic lipids are also beneficial for conditions such as allergies, nausea, vertigo, infections, arthritis, fatigue and pain.
Dr. Revici was able to manage pain effectively with therapeutic lipidss. Many of his patients – including those for whom narcotics and opiates would have been necessary – never required prescription pain medications.
Dr. Revici discovered that tissue pH is either too acid or too alkaline whenever and wherever there is pain in the body. He then identified therapeutic lipids that best reduced or eliminated either acid or alkaline pain. For example, if testing confirmed the tissue pH was too alkaline Dr. Revici would administer therapeutic lipids that arrest and deactivate pro-inflammatory fatty acids that cause the alkaline pain.
Dr. Revici hypothesized that alcohol, drug, and nicotine addictions are anabolic in nature, hence treatable by catabolic agents. He administered lipid-based selenium and sulfur compounds to 3,000 heroin addicts, physically detoxifying the vast majority without withdrawal symptoms.
His study concerning drug addiction and the symptoms of withdrawal is based on the recognition of a dualism, in the pathogenisis of the condition and the action of such agents on the human body. This dualism is shown in the antagonistics of the anabolic(constructive) and catabolic(destructive) conditions, of such agents. Clinically, these catabolic conditions are observed as insomnia, diarrhea, vomiting, cramps, generalized are localized pair, particularly in the bones and joints, and tremors in the patent. The stronger the catabolic condition of the drug agent the more intensive the clinic manifestations.
By applying this research to the problem of any addiction it was found that the agents which induce an addiction have typical anabolic characters, and their action induces a typical anabolic imbalance.
By applying the influence exerted by these various agents upon the oxygen uptake of cancer cells, suspension or yeast, using the YST oxygen monitor, it was found that, over a period of time, the anabolic agents reduced the uptake of oxygen, while the catabolic agents increased it. However, for the anabolic agents, their initial action caused an increase in the oxygen uptake was taking place. This paradoxical action was induced in fact by the action of low amounts of the active agent. This paradoxical action seen in the oxygen uptake test also explains the clinical action with two phases for the addictive drugs studied. The first phase corresponds to a cerebral excitation, followed by a deep sleep.
The recognition of the typical anabolic character for the addicting drugs, represents the first fundamental discovery for the treatment of this problem.
The body defends itself against an anabolic agent which is repeatedly introduced, by manufacturing antagonistic lipids having a catabolic character. Due to its defense character, the body has a tendency to increase its manufacture of the necessary neutralization agents. Due to this reciprocal neutralization, the presence of an excess of the defensive fatty acids requires the need for the drug in order to neutralize it. The more drugs introduced, the more fatty acids are manufactured in a defense action; the more fatty acids are present, the more the need for the drug to neutralize them. This explains the two manifest characters of addiction, the appearance of the need for the drug, and the progressive increase of this need.
In withdrawal, the high amount of the catabolic defense fatty acids remains in the body, since they do not have the anabolic drug to neutralize them. It is the presence of these fatty acids which induce the manifestations of withdrawal. The symptoms are typically catabolic as occur due to the action of the abnormal fatty acids; i.e., insomnia, diarrhea, vomiting, cramps, perspiration, pain in the bones. Analytical data of blood and urine show the presence of such catabolic conditions. The presence of urinary alkalosis indicates the presence of this catabolic imbalance directly affecting the systemic level.
The recognition of a catabolic imbalance, due to the presence of high amounts of noncompensated abnormal fatty acids, constitutes the main character of the drug withdrawal condition. An action upon these fatty acids represents the consequent therapeutic intervention.
The action of selenium was found to work well when used in the bivalent negative state. Bivalent negative selenium has an oxidation character similar to that of the minus 2 of oxygen, and has different effectiveness than the tetra or hexavalent positive oxidation states.
Furthermore, preparations having bivalent negative selenium and lipidic characters are preferred. For this aim, a method for introducing these elements into unsaturated fatty acids was developed.
His method was a blend of clinical observations, laboratory analyses, and chemotherapy. Basically, Revici would analyze the urine, blood, and body temperature and place patients in specific categories based on the "imbalance" that was discovered from these tests. He knew that low body temperature tracks perfectly with immune system strength.
The Romanian-born physician, who practiced in New York City, applied his wide-ranging discoveries for over sixty years to the treatment of cancer as well as many other disorders, including AIDS, arthritis, Alzheimer’s disease, chronic pain, drug addiction, schizophrenia, allergies, shock, and burns. The great majority of his cancer patients were in advanced stages of the illness.
Dr. Revici was the first physician to develop selenium compounds by chemically bonding the mineral selenium to a lipid. Independent validations of Revici’s findings accumulated over the years concerning the development of a safe, effective means of administering selenium to treat cancer.
Revici, who died at a ripe old age of 101, was hounded by the authorities of his time. Dr. Seymour Brenner, a respected radiation oncologist in private practice in New York, testified on Revici’s behalf. He had investigated a number of patients in very advanced stages of cancer, incurable by orthodox means, whom Revici had put into long remissions. Dr. Brenner had an independent panel of pathologists confirm the diagnosis and stage of illness prior to each patient’s initial visit to Revici. He testified that his personal findings strongly suggest Revici has a cancer treatment deserving further study, and he proposed that such an evaluation be conducted by the FDA.
One of his titanic discoveries was understanding the process of what has become known as the anabolic/catabolic metabolic balance. The anabolic/catabolic forces are involved in almost everything in the body. Failing to understand the importance of these fundamental life processes could cost you your health.
Dr. Revici's text: "Research in Physiopathology as Basis of Guided Chemotherapy" was published in 1961. This text is extraordinarily complex, is out of print and is very difficult to find. It yields an incredible amount of vital information regarding Revici's complex theories, the effects of electrostatic and quantum forces upon the body, his explanation of the anaerobic and dysaerobic factors, various orthomolecular agents that are effective at controlling these imbalances, and much more than this.
Dr. Revici successfully cured patients of cancer, put full blown AIDS patients into remission, cured heroin addiction in 3 days, successfully treated mental illness and significantly improved people's lives and reduced human suffering.
Cellular metabolism is the fundamental process with how energy can be produced from nutrients and oxygen. Understanding the differences between the 2 metabolic states of anaerobic and dysaerobic can mean the difference between life and death, health and disease and fast recovery versus slow recovery. There is probably not a single clinical health condition that does not involve an anaerobic or dysaerobic imbalance.
Revici is recognized as the first physician to demonstrate the potency of the trace mineral Selenium in various cancers and states of metabolic imbalance. His discoveries of selenium pre-dated conventional understanding by several decades.
Anaerobic metabolism is the anabolic processes of cellular building. In an anaerobic imbalance there is excess anabolic activity taking place. Instead of producing energy with oxygen, a person is relying on lactic acid fermentation. This is very inefficient. Because an anaerobic patient tends to have a decrease in cell membrane permeability, there is insufficient fatty acid activity and excess sterol activity. When anaerobic conditions are prevalent, cell membranes are too tight, nutrients and oxygen are not used properly by the cells. This contributes to excess intra-cellular acidity, excess potassium in the cells and can derail function in various organs, and systems in the body.
Revici used various methods to determine anaerobic/dysaerobic imbalances. He had a very complex way of interpreting blood chemistry, which included the importance of measuring the levels of intracellular (not serum) potassium. He also used urine testing such as the measurement of urinary surface tension, specific gravity and urine pH.
Dr. Revici’s observations led him to the discovery of “therapeutic agents”, as he called select lipids he administered to countless patients during a span of seven decades. These lipids not only induced significant remissions in many cancers, they did so without any side effects.
Dr. Revici also proved his therapeutic lipids were very effective in the treatment of a host of acute and chronic conditions besides cancer. These include hypertension, cardiovascular disease, addictions, diabetes and autoimmune diseases. Therapeutic lipids are also beneficial for conditions such as allergies, nausea, vertigo, infections, arthritis, fatigue and pain.
Dr. Revici was able to manage pain effectively with therapeutic lipidss. Many of his patients – including those for whom narcotics and opiates would have been necessary – never required prescription pain medications.
Dr. Revici discovered that tissue pH is either too acid or too alkaline whenever and wherever there is pain in the body. He then identified therapeutic lipids that best reduced or eliminated either acid or alkaline pain. For example, if testing confirmed the tissue pH was too alkaline Dr. Revici would administer therapeutic lipids that arrest and deactivate pro-inflammatory fatty acids that cause the alkaline pain.
Dr. Revici hypothesized that alcohol, drug, and nicotine addictions are anabolic in nature, hence treatable by catabolic agents. He administered lipid-based selenium and sulfur compounds to 3,000 heroin addicts, physically detoxifying the vast majority without withdrawal symptoms.
His study concerning drug addiction and the symptoms of withdrawal is based on the recognition of a dualism, in the pathogenisis of the condition and the action of such agents on the human body. This dualism is shown in the antagonistics of the anabolic(constructive) and catabolic(destructive) conditions, of such agents. Clinically, these catabolic conditions are observed as insomnia, diarrhea, vomiting, cramps, generalized are localized pair, particularly in the bones and joints, and tremors in the patent. The stronger the catabolic condition of the drug agent the more intensive the clinic manifestations.
By applying this research to the problem of any addiction it was found that the agents which induce an addiction have typical anabolic characters, and their action induces a typical anabolic imbalance.
By applying the influence exerted by these various agents upon the oxygen uptake of cancer cells, suspension or yeast, using the YST oxygen monitor, it was found that, over a period of time, the anabolic agents reduced the uptake of oxygen, while the catabolic agents increased it. However, for the anabolic agents, their initial action caused an increase in the oxygen uptake was taking place. This paradoxical action was induced in fact by the action of low amounts of the active agent. This paradoxical action seen in the oxygen uptake test also explains the clinical action with two phases for the addictive drugs studied. The first phase corresponds to a cerebral excitation, followed by a deep sleep.
The recognition of the typical anabolic character for the addicting drugs, represents the first fundamental discovery for the treatment of this problem.
The body defends itself against an anabolic agent which is repeatedly introduced, by manufacturing antagonistic lipids having a catabolic character. Due to its defense character, the body has a tendency to increase its manufacture of the necessary neutralization agents. Due to this reciprocal neutralization, the presence of an excess of the defensive fatty acids requires the need for the drug in order to neutralize it. The more drugs introduced, the more fatty acids are manufactured in a defense action; the more fatty acids are present, the more the need for the drug to neutralize them. This explains the two manifest characters of addiction, the appearance of the need for the drug, and the progressive increase of this need.
In withdrawal, the high amount of the catabolic defense fatty acids remains in the body, since they do not have the anabolic drug to neutralize them. It is the presence of these fatty acids which induce the manifestations of withdrawal. The symptoms are typically catabolic as occur due to the action of the abnormal fatty acids; i.e., insomnia, diarrhea, vomiting, cramps, perspiration, pain in the bones. Analytical data of blood and urine show the presence of such catabolic conditions. The presence of urinary alkalosis indicates the presence of this catabolic imbalance directly affecting the systemic level.
The recognition of a catabolic imbalance, due to the presence of high amounts of noncompensated abnormal fatty acids, constitutes the main character of the drug withdrawal condition. An action upon these fatty acids represents the consequent therapeutic intervention.
The action of selenium was found to work well when used in the bivalent negative state. Bivalent negative selenium has an oxidation character similar to that of the minus 2 of oxygen, and has different effectiveness than the tetra or hexavalent positive oxidation states.
Furthermore, preparations having bivalent negative selenium and lipidic characters are preferred. For this aim, a method for introducing these elements into unsaturated fatty acids was developed.
Revici, who holds patents for his numerous chemical compounds, devised a novel technique to open double bonds in molecules of unsaturated fatty acids in order to incorporate different metallic elements at precise points in the molecules. The result is an entirely new series of therapeutic compounds, exceedingly low in toxicity and incorporating selenium, copper, sulfur, zinc, calcium and other elements. In general, these compounds reportedly have a toxicity less than one-thousandth of that of the elements in the forms normally available. His revolutionary techniques converted toxic substances into safe anticancer agents.
Revici’s use of selenium in the treatment of cancer predates mainstream interest in this mineral by more than twenty years. Selenium is one of the major trace elements always found deficient in cancer-prone populations. Research has shown that it is of value not only in preventing cancer but also in treating it. Revici used a special molecular form of selenium (bivalent-negative selenium) incorporated in a molecule of fatty acid.
In this form, he was able to administer up to 1 gram of selenium per day, which corresponds to 1 million micrograms per day, reportedly with no toxic side effects. In contrast, too much selenite (hexavalent-positive selenium) has toxic effects on animals, so human intake of commercial selenite is limited to a dosage of only 100 to 150 micrograms by mouth. Dr. Revici often administered his nontoxic form of selenium by injection, usually considered to be four times more powerful than the form given orally.
Revici’s use of selenium in the treatment of cancer predates mainstream interest in this mineral by more than twenty years. Selenium is one of the major trace elements always found deficient in cancer-prone populations. Research has shown that it is of value not only in preventing cancer but also in treating it. Revici used a special molecular form of selenium (bivalent-negative selenium) incorporated in a molecule of fatty acid.
In this form, he was able to administer up to 1 gram of selenium per day, which corresponds to 1 million micrograms per day, reportedly with no toxic side effects. In contrast, too much selenite (hexavalent-positive selenium) has toxic effects on animals, so human intake of commercial selenite is limited to a dosage of only 100 to 150 micrograms by mouth. Dr. Revici often administered his nontoxic form of selenium by injection, usually considered to be four times more powerful than the form given orally.
Sulfur in lipid form
http://supplements2health.com/ysulfur.html
http://supplements2health.com/ysulfur.html
Selenium in lipid form
http://www.whnstore.com/Revici-Selenated-Tung-Oil-p/sup-tsel-1oz.htm
http://www.whnstore.com/Revici-Selenated-Tung-Oil-p/sup-tsel-1oz.htm
Articles:
